Xilio Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xilio therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xilio Therapeutics Inc Today - Breaking & Trending Today

Short Interest in Xilio Therapeutics, Inc. (NASDAQ:XLO) Increases By 600.2%

Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 379,500 shares, an increase of 600.2% from the March 31st total of 54,200 shares. Based on an average trading volume of 1,170,000 shares, […] ....

Gilead Sciences Inc , Xilio Therapeutics Company Profile , Xilio Therapeutics Inc , Xilio Therapeutics , Get Free Report , Gilead Sciences , Free Report , Xilio Therapeutics Daily , Nasdaq Xlo ,

Gilead Sciences Announces First Quarter 2024 Financial Results

25.04.2024 - Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations. “Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, . ....

Foster City , United States , Complera Eviplera , Kevin Lofton , Sofosbuvir Velpatasvir , Anthony Welters , European Union , Immunomedics Inc , Xilio Therapeutics Inc , Janssen Sciences Ireland Unlimited Company , Gilead Sciences , Merck Co Inc , Department Of Corrections , Tmunity Therapeutics Inc , Gilead Public Affairs Department , Cymabay Therapeutics Inc , Drug Administration , Gilead Sciences Stock , Gilead Sciences Inc , Merck Sharp Dohme , Asegua Therapeutics , Mirobio Ltd , Liver Disease , Cymabay Therapeutics , Gross Margin , Operating Expenses ,

Xilio Therapeutics, Inc. (NASDAQ:XLO) Major Shareholder Purchases $368,790.00 in Stock

Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) major shareholder Gilead Sciences, Inc. acquired 485,250 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $0.76 per share, for a total transaction of $368,790.00. Following the completion of the acquisition, the insider now owns […] ....

United States , Trustees Of Columbia University , Xilio Therapeutics Inc , America Corp , Gilead Sciences Inc , Bridgeway Capital Management , Vanguard Group Inc , Xilio Therapeutics Company Profile , Xilio Therapeutics , Get Free Report , Gilead Sciences , Columbia University , New York , Capital Management , State Street Corp , Street Corp , Xilio Therapeutics Daily , Nasdaq Xlo , Insider Trading , Nsider Trades ,

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket - Doma Holdings (NYSE:DOMA)

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading ....

Josh Siegler , Ch Auto Technology , Doma Holdings Inc , Sintx Technologies Inc , Holdings Co Ltd , Vivos Therapeutics Inc , Torrid Holdings Inc , Therapeutics Inc , Xilio Therapeutics Inc , Cleanspark Inc , Zapata Computing Holdings Inc , Sunshine Biopharma Inc , Fractyl Health Inc , Pavmed Inc , Life Sciences Inc , Galera Therapeutics Inc , Cantor Fitzgerald , Qilian International Holding Group Limited , Gilead Sciences , Mountain Crest Acquisition Corp , Doma Holdings , Mediaco Holding Inc , Oxford Industries Inc , Renewables Limited , Avalo Therapeutics Inc , Mountain Crest Acquisition ,

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer in the. ....

Rock Springs , United States , San Diego , Melissa Forst , Dan Budwick , Xilio Therapeutics Inc , American Association For Cancer Research , Roche Group , Research Development Rd Expenses , Gilead Sciences Inc , Exchange Commission , Pacific Western Bank , Bain Capital Life Sciences , Genentech United States Inc , Xilio Therapeutics , Gilead Sciences , Activated Bispecific , Immune Cell Engager , American Association , Cancer Research , Annual Meeting , Fourth Quarter , Regarding Forward Looking , Private Securities Litigation Reform Act , Quarterly Report , Genentech United States ,